2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$7.24+$0.34 (+4.93%)
Price as of Jun 23, 2026 7:19 PM EDT- $1.2BMarket Cap
- 48.71%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$7.24+$0.34 (+4.93%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 283.0M +39.36% | 203.1M +23.89% | 163.9M +48.68% | 110.2M +122.32% | |
Cost of Revenue | 42.6M +15.58% | 36.8M +28.58% | 28.6M +26.56% | 22.6M +69.95% | |
Gross Profit | 240.4M +44.63% | 166.2M +22.89% | 135.3M +54.39% | 87.6M +141.55% | |
Sales and Marketing Expense | 182.4M +11.56% | 163.5M +11.90% | 146.1M +6.06% | 137.7M +9.57% | |
Research and Development Expense | -31.2M +21.93% | -25.6M +14.41% | -22.3M +6.56% | -21.0M -16.67% | |
Depreciation and Amortization Expense | 10.8M 0.00% | 10.8M 0.00% | 10.8M 0.00% | 10.8M +1,871.45% | |
Total Operating Expenses | 449.3M +12.27% | 400.2M +13.04% | 354.0M +7.30% | 329.9M +13.59% | |
Operating Profit | 24.9M +173.99% | -33.6M -23.55% | -44.0M -46.29% | -81.9M -28.84% | |
Interest Income | 4.7M -10.88% | 5.3M +12.00% | 4.8M +84.29% | 2.6M +723.64% | |
Interest Expense | N/A N/A | N/A N/A | -26.6M +73.63% | -15.3M +113.44% | |
Interest Income and Expense and Net | 4.7M -10.88% | 5.3M +124.34% | -21.9M +71.48% | -12.7M +85.63% | |
Total Nonoperating Income and Expense | -24.3M +3.77% | -23.5M +20.33% | -19.5M +37.83% | -14.1M +86.87% | |
Income before Taxes | 554,000 +100.97% | -57.1M -10.08% | -63.5M -33.91% | -96.1M -21.71% | |
Income Taxes | 0 +100.00% | -2.3M +81.59% | -1.2M -12.29% | -1.4M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 554,000 +101.01% | -54.8M -11.92% | -62.3M -34.23% | -94.7M -22.87% | |
Net Income from Continuing Operations Applicable to Common | 554,000 +101.01% | -54.8M -11.92% | -62.3M -34.23% | -94.7M -22.87% | |
Basic EPS and Net Income | 0.00 +100.00% | -0.37 -17.78% | -0.45 -35.71% | -0.70 -54.84% | |
Diluted EPS and Net Income | 0.00 +100.00% | -0.37 -17.78% | -0.45 -35.71% | -0.70 -54.84% | |
Basic Weighted Average Shares | 160.4M +9.30% | 146.8M +6.61% | 137.7M +1.51% | 135.6M +71.62% | |
Diluted Weighted Average Shares | 172.7M +17.69% | 146.8M +6.61% | 137.7M +1.51% | 135.6M +71.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 111.0M +55.04% | 71.6M +6.19% | 67.4M -44.70% | 122.0M +81.31% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 5.0M N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 111.0M +55.04% | 71.6M -1.15% | 72.5M -40.60% | 122.0M +19.07% | |
Total Current Assets | 240.3M +43.33% | 167.7M +7.29% | 156.3M -16.35% | 186.8M +31.01% | |
Accumulated Depreciation | 8.2M +12.58% | 7.3M +20.33% | 6.0M +9.07% | 5.5M +33.83% | |
Property and Plant and Equipment and Net | 4.9M -11.09% | 5.6M -6.85% | 6.0M +8.25% | 5.5M -16.76% | |
Total Long-Term Assets | 5.2M -3.46% | 5.4M +19.10% | 4.5M -4.02% | 4.7M +470.57% | |
Total Assets | 383.5M +18.72% | 323.1M +0.14% | 322.6M -6.36% | 344.5M +13.20% | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 2.3M -35.53% | 3.5M -28.81% | |
Total Short-Term Debt | 0 -100.00% | 15.1M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 109.6M +9.09% | 100.4M +5.52% | 95.2M +29.30% | 73.6M -6.86% | |
Total Long-Term Debt | 220.3M +1.53% | 217.0M +13.66% | 190.9M +2.06% | 187.1M +112.42% | |
Total Long-Term Liabilities | 8.4M +326.94% | 2.0M -59.43% | 4.8M +15,538.71% | 31,000 -98.15% | |
Total Liabilities | 369.8M +4.87% | 352.7M +7.07% | 329.4M +10.04% | 299.3M +43.13% | |
Retained Earnings | -671.3M -0.08% | -671.9M +8.89% | -617.0M +11.22% | -554.8M +20.57% | |
Total Stockholders Equity | 13.7M +146.22% | -29.6M +336.67% | -6.8M -115.01% | 45.2M -52.55% | |
Total Shares Outstanding | 166.2M +11.23% | 149.4M +8.18% | 138.1M +1.36% | 136.3M +9.13% | |
Cash Flow | |||||
Cash from Operating Activities | 28.6M +177.41% | -37.0M -21.36% | -47.0M -54.30% | -102.9M +7.70% | |
Capital Expenditures | -696,000 -19.82% | -868,000 -61.64% | -2.3M +331.87% | -524,000 -148.29% | |
Cash from Investing Activities | -696,000 -114.25% | 4.9M +181.33% | -6.0M -117.42% | 34.5M -64.82% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.4M -68.51% | 36.2M +2,342.28% | -1.6M -101.27% | 127.5M +367.84% | |
Financials Ratio | |||||
Gross Margin | 84.96% +3.78% | 81.86% -0.80% | 82.52% +3.84% | 79.47% N/A | |
Operating Margin | 8.80% +153.09% | -16.57% -38.29% | -26.85% -63.87% | -74.32% N/A | |
Return on Assets | 0.16% +100.92% | -16.99% -8.99% | -18.66% -36.03% | -29.18% N/A | |
Return on Equity | -6.96% -102.31% | 301.32% +192.94% | -324.20% +140.46% | -134.83% N/A | |
Revenue Growth | 39.36% +64.78% | 23.89% -50.93% | 48.68% -60.20% | 122.32% N/A | |
Current Ratio | 2.19 +31.39% | 1.67 +1.69% | 1.64 -35.31% | 2.54 N/A | |
Cash Ratio | 1.01 +42.11% | 0.71 +0.65% | 0.71 -57.23% | 1.66 N/A | |
Debt-to-Equity Ratio | 16.10 +305.37% | -7.84 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.57 -20.04% | 0.72 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow